This is a community-generated profile. If you work at Synosia Therapeutics, to claim it.
Synosia Therapeutics Funding
$91.5M
33 rounds
Synosia Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 3 rounds, totaling in an amount of $91.5M. Their most recent funding was raised on October 12, 2010.
Funding Rounds
C
$30000000B
$29000000U
$32500000Investors of Synosia Therapeutics
Abingworth
Novo Holdings
UCB Pharma
Develops meds for neurology & immunology diseases
Versant Ventures
5AM Ventures
Investor Growth Capital
Novo A/S
Aravis Ventures
